Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Optimum Axillary Dissection in Breast Cancer—is Angular Vein a Reliable Spatial Landmark?

Optimum Axillary Dissection in Breast Cancer—is Angular Vein a Reliable Spatial Landmark? Indian J Surg Oncol (July–September 2010) 1(3):214–215 DOI 10.1007/s13193-011-0056-8 EDITORIAL Optimum Axillary Dissection in Breast Cancer—is Angular Vein a Reliable Spatial Landmark? Chintamani Published online: 18 March 2011 Indian Association of Surgical Oncology 2011 axilla is mandatory. Regarding various anatomical end points for optimum axillary dissection there are no definite guidelines and optimum axillary dissection is often a subject of controversy. Some surgeons consider clearance of levels-I and II to be optimum while most surgeons would like to dissect up to level-III. It is often debated that clearing level-III may actually add to the morbidity of axillary vein thrombosis and lymphaedema without rendering any survival advantage. The counter argument to this thought is related to the inadequacy of dissection defeating the therapeutic intent of axillary clearance. The morbidity of axillary clearance up to level-III is minimal at the hands of experienced surgeons at a Chintamani Axillary lymph nodes are the surrogate markers of outcome in patients with breast cancer. The survival drops by nearly 50% in patients with positive axillae. The “gold standard” method of assessing the axilla is to establish the histological evidence of disease in the nodes, making assessment of axilla mandatory even in node negative patients http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Indian Journal of Surgical Oncology Springer Journals

Optimum Axillary Dissection in Breast Cancer—is Angular Vein a Reliable Spatial Landmark?

Chintamani
Indian Journal of Surgical Oncology , Volume 1 (3): 2 – Sep 1, 2010
Download PDF
2 pages

Loading next page...
 
/lp/springer-journals/optimum-axillary-dissection-in-breast-cancer-is-angular-vein-a-8n8XePmwO1

References (4)

Publisher
Springer Journals
Copyright
2011 Indian Association of Surgical Oncology
ISSN
0975-7651
eISSN
0976-6952
DOI
10.1007/s13193-011-0056-8
Publisher site
See Article on Publisher Site

Abstract

Indian J Surg Oncol (July–September 2010) 1(3):214–215 DOI 10.1007/s13193-011-0056-8 EDITORIAL Optimum Axillary Dissection in Breast Cancer—is Angular Vein a Reliable Spatial Landmark? Chintamani Published online: 18 March 2011 Indian Association of Surgical Oncology 2011 axilla is mandatory. Regarding various anatomical end points for optimum axillary dissection there are no definite guidelines and optimum axillary dissection is often a subject of controversy. Some surgeons consider clearance of levels-I and II to be optimum while most surgeons would like to dissect up to level-III. It is often debated that clearing level-III may actually add to the morbidity of axillary vein thrombosis and lymphaedema without rendering any survival advantage. The counter argument to this thought is related to the inadequacy of dissection defeating the therapeutic intent of axillary clearance. The morbidity of axillary clearance up to level-III is minimal at the hands of experienced surgeons at a Chintamani Axillary lymph nodes are the surrogate markers of outcome in patients with breast cancer. The survival drops by nearly 50% in patients with positive axillae. The “gold standard” method of assessing the axilla is to establish the histological evidence of disease in the nodes, making assessment of axilla mandatory even in node negative patients

Journal

Indian Journal of Surgical Oncology – Springer Journals

Published: Sep 1, 2010

Keywords: surgical oncology; oncology; surgery

There are no references for this article.